Suppr超能文献

糖尿病肾病中尿补体激活的病理意义:从疾病发展的全面视角。

Pathological significance of urinary complement activation in diabetic nephropathy: A full view from the development of the disease.

机构信息

Department of Nephrology Taizhou Hospital, Wenzhou Medical University, Lihai, Zhejiang Province, China.

National Clinical Research Center of Kidney Diseases, Jingling Hospital, Nanjing University School of Medicine, Nanjing, China.

出版信息

J Diabetes Investig. 2019 May;10(3):738-744. doi: 10.1111/jdi.12934. Epub 2018 Oct 13.

Abstract

AIMS/INTRODUCTION: The aim of the present study was to obtain a full view of the changes of urinary complement activation products in the development of diabetic nephropathy and explore their possible significance in the disease process.

MATERIALS AND METHODS

A total of 62 patients at different stages of diabetic nephropathy, 20 diabetes patients without nephropathy and 20 healthy persons were enrolled. Urinary complement activation products, including C3a, C5a and C5b-9, were measured, and their associations with the progression of the disease were analyzed.

RESULTS

The urinary complement activation products increased markedly since the proteinuria stage, and were parallel with the progression of diabetic nephropathy. More severe renal tubular damage was observed in patients with higher levels of urinary complement activation products. The urinary complement activation products levels correlated closely with renal tubulointerstitial injury score and relative tubular interstitial volume. Multivariate regression analysis showed that elevated urinary complement activation products were independent risk factors for tubular injury in diabetic nephropathy patients.

CONCLUSIONS

Urinary complement activation might have a role in renal tubular interstitial injury in patients with diabetic nephropathy, especially in patients at a later stage of the disease.

摘要

目的/引言:本研究旨在全面观察糖尿病肾病发展过程中尿补体激活产物的变化,并探讨其在疾病进程中的可能意义。

材料与方法

共纳入 62 例不同阶段的糖尿病肾病患者、20 例无肾病的糖尿病患者和 20 名健康人。检测尿补体激活产物,包括 C3a、C5a 和 C5b-9,并分析其与疾病进展的关系。

结果

尿补体激活产物自蛋白尿期开始明显升高,并与糖尿病肾病的进展平行。尿补体激活产物水平较高的患者,肾小管损伤更严重。尿补体激活产物水平与肾间质损伤评分及肾小管间质相对体积密切相关。多变量回归分析显示,尿补体激活产物升高是糖尿病肾病患者肾小管损伤的独立危险因素。

结论

尿补体激活可能在糖尿病肾病患者的肾小管间质损伤中起作用,尤其是在疾病晚期患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f68a/6497774/b3ae07ec87d7/JDI-10-738-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验